|
|||||
|
|
| 颅内动脉粥样硬化性狭窄 | |
| 引用本文： | 郭瑞友,侯荣耀,马腾. 颅内动脉粥样硬化性狭窄[J]. 国外医学:脑血管疾病分册, 2014, 0(10): 767-772 |
| 作者姓名： | 郭瑞友 侯荣耀 马腾 |
| 作者单位： | 青岛大学医学院附属海慈医院神经内科,266033 |
| 摘 要： | 颅内动脉粥样硬化性狭窄（intracranial atherosclerotic stenosis，ICAS）是缺血性卒中发生、发展和复发的重要原因，年龄、高血压、糖尿病、吸烟等是其传统危险因素。其中，有症状ICAS是临床干预的重点，治疗方法包括强化药物治疗、血管内介入治疗、颅内外血管旁路移植术、脑硬脑膜动脉联合成形术和体外反搏术等。 |
| 关 键 词： | 颅内动脉硬化 卒中 脑缺血 抗血小板聚集药 羟甲基戊二酰基CoA还原酶抑制剂 血管成形术 支架 危险因素 |
Intrac ranial atherosclerotic stenosis |
|
| GUO Ruiyou,HOU Rongyao,MA Teng. Intrac ranial atherosclerotic stenosis[J]. Foreign Medical Sciences Cerebrovascular Diseases, 2014, 0(10): 767-772 | |
| Authors: | GUO Ruiyou HOU Rongyao MA Teng |
| Affiliation: | (Department of Neurology, the Affiliated Hiser Hospital of Qingdao University Medical College, Qingdao 266033, China) |
| Abstract: | Intracranial atherosclerotic stenosis （ICAS） is an important cause for the occurrence, development, and recurrence of ischemic stroke. Age, hypertension, diabetes, and smoking etc. are its traditional risk factors. Among them, symptomatic ICAS is the key of clinical intervention. Its treatments include intensive medical therapy, endovascular treatment, extracranial intracranial arterial bypass grafting, encephaloduroarteriosynangiosis, and external counterpulsation, etc. |
| Keywords: | Intracranial Arteriosclerosis Stroke Brain Ischemia Platelet Aggregation Inhibitors Hydroxymethylglutaryl-CoA Reductase Inhibitors Angioplasty Stents Risk Factors |
| 本文献已被 维普 等数据库收录！ | |